Mammary carcinoma in cats: treatment, prognosis and clinical trials

Cats · USA & Canada

Understanding mammary carcinoma

Feline mammary carcinoma is usually a biologically aggressive cancer. Smaller tumors found before lymph-node or lung spread generally carry a better outlook than larger or metastatic tumors. Tumor size, grade, lymphovascular invasion and stage are the key pieces owners should ask about.

What does the prognosis look like?

Early, complete surgery offers the best chance of longer control, so a confirmed or strongly suspected tumor should not simply be watched. Smaller tumors without lymph-node or lung spread generally have better outcomes, but recurrence and spread remain real concerns. After surgery, the pathology report and staging determine whether chemotherapy should be discussed and how closely your cat should be monitored.

What matters next

Measure all mammary tumors and evaluate regional lymph nodes and the chest before surgery is treated as the only decision. In cats, the extent of mammary surgery can matter. Afterward, tumor size, grade, margins, lymphovascular invasion and node status help determine whether additional treatment should be discussed.

Where are you now?

The mammary tumor is still present

Record tumor size and multiplicity, assess regional nodes and lungs as appropriate, and decide the intended extent of surgery before operating rather than treating only the most obvious nodule.

Surgery has already been done

Review tumor size, grade, measured margins, lymphovascular invasion, and lymph-node status. Those findings determine recurrence risk and whether additional treatment is worth discussing.

A regional lymph node is positive

Nodal metastasis is an important adverse finding. Complete staging and discuss systemic treatment; make sure the sampled node actually drains the affected mammary region.

There is metastatic, ulcerated, or recurrent disease

Systemic treatment and comfort become central. Local surgery or radiation may still help selected painful, infected, ulcerated, or bleeding lesions when the expected benefit justifies recovery.

If you are waiting for oncology

Feline mammary carcinoma is often aggressive, so stage before assuming surgery alone is enough. Record tumor size and multiplicity, assess regional nodes and lungs, and plan the extent of surgery intentionally.

Questions to ask your oncologist

What are the tumor size, grade, lymphovascular invasion and node status?
What extent of mammary surgery is recommended for this pattern?
Does this risk profile justify chemotherapy or closer metastatic monitoring?

How the diagnosis may appear in the record

Record every mammary mass and its size. Useful pathology includes tumor type, grade, measured margins, lymphovascular invasion, and regional lymph-node status. Feline mammary tumors should not be assigned the generally more variable behavior of canine mammary tumors.

Changes to watch for at home

Track growth, new nodules, redness, ulceration, discharge, bleeding, pain, or swelling near regional nodes. Cats may hide discomfort; reduced grooming, hiding, or reluctance to lie in a normal position can matter. Breathing difficulty or uncontrolled bleeding needs prompt care.

How it is usually treated

Surgery is the main treatment for localized feline mammary carcinoma, and the surgical plan is often more extensive than simply removing one visible nodule. Chemotherapy may be discussed for higher-risk, node-positive or metastatic disease, although expected benefit varies between cats.

What can affect treatment choices

Tumor size and number, grade, lymphovascular invasion, lymph-node involvement, metastatic stage and the extent of surgery strongly affect risk and treatment.

Tests that may matter

Chest imaging and regional lymph-node assessment help stage the disease. Pathology after surgery should report grade, margins and lymphovascular invasion when possible. Additional biomarker testing should be ordered only when it may change treatment or trial eligibility.

Treatment options available now

2 options currently in our catalog.

Check eligibility

Novel anticancer therapy for metastatic feline mammary carcinoma

Michigan State University · USA

Location

Michigan State University Veterinary Medical Center, 736 Wilson Rd, East Lansing, MI 48824

Study details

Actively recruiting — listed on current MSU Oncology Clinical Trials

What is being offered: Investigational miR-10b-targeted therapeutic administered after baseline CT/MRI, repeated at two weeks and then with monthly imaging/treatment

Who may qualify: Confirmed cancer diagnosis required; Metastatic; Measurable

Costs / coverage: 🟡 Partially funded. Investigational miR-10b therapy and associated MRI/CT imaging are funded; unrelated diagnostics and treatment remain owner-paid.

Contact: MSU Medical Oncology — 517-353-5420; cvm.oncoinfo@msu.edu

Official study / enrollment information →

Olaparib plus meloxicam for feline mammary carcinoma

University of Minnesota Veterinary Medical Center · USA

Location

University of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108

Study details

Open and enrolling

What is being offered: Pilot treatment study combining PARP inhibition with meloxicam for measurable feline mammary carcinoma.

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Min tumor cm: 1

Costs / coverage: 🟡 Partially funded. Screening, study medications and required study visits/labs/imaging are covered; the study also provides a $2,000 surgical credit and up to $1,000 for study-medication complications.

Contact: University of Minnesota Clinical Investigation Center — 612-624-2485; Canine Brain Tumor Program clinical-trials coordinator Sara Pracht

Official study / enrollment information →